{
  "abstract": null,
  "abstract_shown": false,
  "affiliations": [
    "Chengdu Brilliant AcuRNA Biopharmaceutical Co., Ltd.",
    "Brilliant Pharmaceutical Co., Ltd."
  ],
  "article_type": null,
  "arxiv": null,
  "author_total": 10,
  "authors": [
    {
      "affs": [
        0,
        1
      ],
      "name": "Wen Liu",
      "orcid": "0000-0001-8982-0344"
    },
    {
      "affs": [
        0
      ],
      "name": "Shuai Pei"
    },
    {
      "affs": [
        0
      ],
      "name": "Jiaqi Lu"
    },
    {
      "affs": [
        0
      ],
      "name": "Yi Chen",
      "orcid": "0009-0004-7954-1789"
    },
    {
      "affs": [
        0,
        1
      ],
      "name": "Keke Zou"
    },
    {
      "affs": [
        0
      ],
      "name": "Jiachuan Duan"
    },
    {
      "affs": [
        0,
        1
      ],
      "name": "Chao Zang"
    },
    {
      "affs": [
        1
      ],
      "name": "Xiwen Cheng"
    },
    {
      "affs": [
        0,
        1
      ],
      "name": "Haoxi Huang"
    },
    {
      "affs": [
        0,
        1
      ],
      "name": "Yu Chen"
    }
  ],
  "bibtex": "https://research.draconitic.com/paper/a84q1660wr9ya.bib",
  "cited_by": 0,
  "doi": "10.1161/jaha.126.055499",
  "fulltext_url": null,
  "id": "a84q1660wr9ya",
  "issns": [
    "2047-9980"
  ],
  "landing_url": "https://www.ahajournals.org/doi/10.1161/JAHA.126.055499",
  "language": null,
  "licence": "unknown",
  "licence_label": "Licence not stated",
  "licence_source": "unknown",
  "licence_url": null,
  "metadata_licence": null,
  "native_subjects": [],
  "openalex": null,
  "pdf_url": null,
  "pmcid": null,
  "pmid": null,
  "published": "2026-11-06",
  "publisher": "Ovid Technologies (Wolters Kluwer Health)",
  "ris": "https://research.draconitic.com/paper/a84q1660wr9ya.ris",
  "sources": [
    {
      "first_seen": "2026-11-07T00:21:27Z",
      "native_id": "10.1161/jaha.126.055499",
      "source": "crossref",
      "url": "https://www.ahajournals.org/doi/10.1161/JAHA.126.055499"
    }
  ],
  "subjects": [
    {
      "field": "medicine",
      "origin": "issn:2047-9980",
      "subfield": "cardiovascular"
    }
  ],
  "title": "BPR‐30901649, An Angiotensinogen‐Targeting Small Interfering RNA, Achieves Ultra‐Durable Target Silencing and Sustained Blood Pressure Reduction Through 20 Weeks in Hypertensive Non‐Human Primates",
  "title_text": "BPR‐30901649, An Angiotensinogen‐Targeting Small Interfering RNA, Achieves Ultra‐Durable Target Silencing and Sustained Blood Pressure Reduction Through 20 Weeks in Hypertensive Non‐Human Primates",
  "type": "peer-reviewed",
  "updated_at": "2026-11-08T00:23:09Z",
  "url": "https://research.draconitic.com/paper/a84q1660wr9ya",
  "venue": "Journal of the American Heart Association",
  "versions": []
}